Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension

Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension

Abstract Background In idiopathic intracranial hypertension (IIH), sustained weight loss is the main pillar in modifying disease course, whereby glucagon-like peptide-1 receptor agonists (GLP-1-RAs) could present an attractive treatment option. Methods In this open-label, single-center, case–control...

Full description

Bibliographic Details
Main Authors: Nik Krajnc, Bianca Itariu, Stefan Macher, Wolfgang Marik, Jürgen Harreiter, Martin Michl, Klaus Novak, Christian Wöber, Berthold Pemp, Gabriel Bsteh
Format: Article
Language:English
Published: BMC 2023-07-01
Series:The Journal of Headache and Pain
Subjects:
Idiopathic intracranial hypertension
Weight loss
Glucagon-like peptide-1
Headache
Visual worsening
Online Access:https://doi.org/10.1186/s10194-023-01631-z

Internet

https://doi.org/10.1186/s10194-023-01631-z

Similar Items